Application of SILAC Labeling in Phosphoproteomics Analysis.


Journal

Methods in molecular biology (Clifton, N.J.)
ISSN: 1940-6029
Titre abrégé: Methods Mol Biol
Pays: United States
ID NLM: 9214969

Informations de publication

Date de publication:
2021
Historique:
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 24 6 2021
Statut: ppublish

Résumé

The analysis of disease-related changes in the phosphorylation status of cellular signal transduction networks is of major interest to biomedical researchers. Mass spectrometry-based proteomics allows the analysis of phosphorylation in a global manner. However, several technical challenges need to be addressed when the phosphorylation of proteins is analyzed. Low-abundant phosphopeptides need to be enriched before analysis, thereby introducing additional steps in sample preparation. Consequently, the applied quantification strategies should be robust towards elaborate sampling handling, rendering label-based quantification strategies the methods of choice in many experiments. Here, we present a protocol for SILAC labeling and the subsequent isolation of phosphopeptides using TiO

Identifiants

pubmed: 33950491
doi: 10.1007/978-1-0716-1024-4_13
doi:

Substances chimiques

Phosphoproteins 0
Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-183

Références

Chen J, Shinde S, Koch M-H et al (2015) Low-bias phosphopeptide enrichment from scarce samples using plastic antibodies. Sci Rep 5:11,438
doi: 10.1038/srep11438
Ruprecht B, Koch H, Domasinska P et al (2017) Optimized enrichment of phosphoproteomes by Fe-IMAC column chromatography. Methods Mol Biol 1550:47–60
doi: 10.1007/978-1-4939-6747-6_5
Thingholm TE, Jørgensen TJD, Jensen ON et al (2006) Highly selective enrichment of phosphorylated peptides using titanium dioxide. Nat Protoc 1:1929–1935
doi: 10.1038/nprot.2006.185
Brenes A, Hukelmann J, Bensaddek D et al (2019) Multibatch TMT reveals false positives, batch effects and missing values. Mol Cell Proteomics 18:1967–1980
doi: 10.1074/mcp.RA119.001472
Stepath M, Zu B, Maghnouj A et al (2019) Systematic comparison of label-free, SILAC, and TMT techniques to study early adaption toward inhibition of EGFR signaling in the colorectal cancer cell line DiFi. J Proteome Res 19:926–937
doi: 10.1021/acs.jproteome.9b00701
Olive M, Untawale S, Coffey RJ et al (1993) Characterization of the DiFi carcinoma cell line dereives from a familial adenomatous polyposis patient. Vitr Cell Dev Biol 29A:239–248
doi: 10.1007/BF02634191
Park S-S, Wu WW, Zhou Y et al (2012) Effective correction of experimental errors in quantitative proteomics using stable isotope labeling by amino acids in cell culture (SILAC). J Proteome 75:3720–3732
doi: 10.1016/j.jprot.2012.04.035
Lehmann W (2016) A timeline of stable of isotopes and mass spectrometry. Mass Spectrom Rev 36:58–85
doi: 10.1002/mas.21497
Bendall SC, Hughes C, Stewart MH et al (2008) Prevention of amino acid conversion in SILAC experiments with embryonic stem cells. Mol Cell Proteomics 7:1587–1597
doi: 10.1074/mcp.M800113-MCP200
Taleb RSZ, Moez P, Younan D, Eisenacher M et al (2019) Protein biomarker discovery using human blood plasma microparticles. Methods Mol Biol 1959:51–64
doi: 10.1007/978-1-4939-9164-8_4
Dehghani A, Gödderz M, Winter D (2018) Tip-based fractionation of batch-enriched phosphopeptides facilitates easy and robust phosphoproteome analysis. J Proteome Res 17:46–54
doi: 10.1021/acs.jproteome.7b00256
Rappsilber J, Mann M, Ishihama Y (2007) Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using stagetips. Nat Protoc 2:1896–1906
doi: 10.1038/nprot.2007.261
Tyanova S, Cox J (2018) Perseus: a bioinformatics platform for integrative analysis of proteomics data in cancer research. Methods Mol Biol 1711:133–148
doi: 10.1007/978-1-4939-7493-1_7
Tyanova S, Temu T, Sinitcyn P et al (2016) The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods 13:731–740
doi: 10.1038/nmeth.3901

Auteurs

Markus Stepath (M)

Medizinisches Proteom-Center (MPC), Medical Faculty, Ruhr-Universität Bochum, Bochum, Germany.
Medical Proteome Analysis, Center for Proteindiagnostics (PRODI), Ruhr-University Bochum, Bochum, Germany.

Thilo Bracht (T)

Medizinisches Proteom-Center (MPC), Medical Faculty, Ruhr-Universität Bochum, Bochum, Germany. thilo.bracht@rub.de.
Medical Proteome Analysis, Center for Proteindiagnostics (PRODI), Ruhr-University Bochum, Bochum, Germany. thilo.bracht@rub.de.
Klinik für Anästhesiologie, Intensivmedizin und Schmerztherapie, Universitätsklinikum Knappschaftskrankenhaus Bochum, Bochum, Germany. thilo.bracht@rub.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH